Fulcrum Therapeutics (FULC)'s 30-day implied volatility (IV30) was 34.6% at the close on November 6, 2026, down from 38.0% the day before, against a 52-week range of 24.0% to 187.4%. Its 20-day historical volatility was 22.7%.
Data as of November 6, 2026.